Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression

World Journal of Gastroenterology

Volumn 10, Issue 12, 2004, Pages 1716-1721

  Kazemi Noureini, Sakineh ^a   Colonna Romano, Sergio ^b   Ziaee, Abed Ali ^a   Malboobi, Mohammad Ali ^c   Yazdanbod, Mansour ^d   Setayeshgar, Parviz ^e   Maresca, Bruno ^b,f  

^a UNIVERSITY OF TEHRAN   (Iran)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c NRCGEB   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Madaen Hospital   (Iran)

^f UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDOKETO REDUCTASE; COMPLEMENTARY DNA; OLIGONUCLEOTIDE; PRIMER DNA; PRIMER RNA; PROTEIN MAL; RAB PROTEIN; RNA; SEX HORMONE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; FROZEN SECTION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE SWITCHING; GENE TARGETING; GENETIC HETEROGENEITY; HUMAN; HUMAN GENOME; HUMAN TISSUE; ISOTOPE LABELING; MALE; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PROTEIN MOTIF; RNA EXTRACTION; RNA ISOLATION; SLOT BLOT HYBRIDIZATION; SQUAMOUS CELL CARCINOMA; STEROID METABOLISM; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 3142706730     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i12.1716     Document Type: Article

References (46)

1. Saidi F, Sepehr A, Fahimi S, Farahvash MJ, Salehian P, Esmailzadeh A, Keshoofy M, Pirmoazen N, Yazdanbod M, Roshan MK. Oesophageal cancer among the Turkomans of northeast Iran. Br J Cancer 2000; 83: 1249-1254
2. Munoz N. Epidemiological aspects of oesophageal cancer. Endoscopy 1993; 23: 609-612
3. Lam AK. Molecular biology of oesophageal squamous cell carcinoma. Crit Rev Oncol Hematol 2000; 33: 71-90
4. Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 2000; 462: 335-342
5. Graber MW, Schweinfest CW, Reed CE, Papas TS, Baron PL. Isolation of differentially expressed genes in carcinoma of the esophagus. Ann Surg Oncol 1996; 3: 192-197
6. Xu Z, Wang MR, Xu X, Cai Y, Han YL, Wu KM, Wang J, Chen BS, Wang XQ, Wu M. Novel human esophagus-specific gene C1orf10: cDNA cloning, gene structure, and frequent loss of expression in oesophageal cancer. Genomics 2000; 69: 322-330
7. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1 and CDC25B genes in ESCC. Clin Cancer Res 2001; 7: 2213-2221
8. Zhou J, Zhao LQ, Xiong MM, Wang XQ, Yang GR, Qiu ZL, Wu M, Liu ZH. Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9: 9-15
9. Rastegar-Jazii F, Ziaee AA, Yazdanbod M. Application of two-dimensional electrophoresis and HIH 3T3 cell transfection assay in the study of tumor-associated proteins and genomic DNA tumorigenicity in malignant human oesophageal specimens. J Sciences IRI 1998; 9: 216-225
10. Sepehr A, Taniere P, Martel-Planche G, Ziaee AA, Rastegar-Jazi F, Yazdanbod M, Etemad-Moghadam G, Kamangar F, Saidi F, Hainaut P. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene 2001; 20: 7368-7374
11. Watanabe H, Jass JR, Sobin LH. Histological typing of oesophageal and gastric tumors. In: International Histological Classification of Tumors, Ed. 2. Berlin: Springer-Verlag 1990
12. Burland TG. DNASTAR's Lasergene sequence analysis software. Methods Mol Biol 2000; 132: 71-91
13. Gish W, States DJ. Identification of protein coding regions by database similarity search. Nat Genet 1993; 3: 266-272
14. Pertsemlidis A, Fondon JW 3rd. Having a BLAST with bioinformatics (and avoiding BLASTphemy). Genome Biol 2001; 2: REVIEWS 2002
15. Bateman A, Birney E, Durbin R, Eddy SR, Howe KL, Sonnhammer ELL. The Pfam protein families database. Nucleic Acid Res 2000; 28: 263-266
16. Attwood TK, Croning MD, Flower DR, Lewis AP, Mabey JE, Scordis P, Selley NL, Wright W. PRINTS-S: the database formerly known as PRINTS. Nucleic Acid Res 2000; 28: 225-227
17. Attwood TK, Blythe MJ, Flower DR, Gaulton A, Mabey JE, Maudling N, McGregor L, Mitchell AL, Moulton G, Paine K, Scordis P. PRINTS and PRINTS-S shed light on protein ancestry. Nucleic Acids Res 2002; 30: 239-241
18. Pietrokovski S. Searching databases of conserved seqeuence regions by aligning protein multiple-alignments. Nucleic Acids Res 1996; 24: 3836-3845
19. Schultz J, Copley RR, Doerks T, Ponting CP, Bork P. A web-based tool for the study of genetically mobile domains. Nucleic Acid Res 2000; 28: 231-234
20. Letunic I, Goodstadt L, Dickens NJ, Doerks T, Schultz J, Mott R, Ciccarelli F, Copley RR, Ponting CP, Bork P. Recent improvements to the SMART domain-based sequence annotation resource. Nucleic Acids Res 2002; 30: 242-244
21. Falquet L, Pagni M, Bucher P, Hulo N, Sigrist CJ, Hofmann K, Bairoch A. The PROSITE database, its status in 2002. Nucleic Acids Res 2002; 30: 235-238
22. Nakai K, Horton P. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 1999; 24: 34-36
23. Wang Z, Wang M, Xu X, Xu Z, Han Y, Cai Y, Sun Y, Wu M. Studies of MAL gene in human oesophageal cancer by RNA in situ hybridization. Zhonghua Yixue Yichuanxue Zazhi 2000; 17: 329-331
24. Alonso MA, Weissman SM. cDNA cloning and sequence of MAL, a hydrophobic protein associated with human T-cell differentiation. Proc Natl Acad Sci U S A 1987; 84: 1997-2001
25. Liebert M, Hubbel A, Chung M, Wedemeyer G, Lomax MI, Hegeman A, Yuan TY, Brozovich M, Wheelock MJ, Grossman HB. Expression of mal is associated with urothelial differentiation in vitro: identification by differential display reverse-transcriptase polymerase chain reaction. Differentiation 1997; 61: 177-185
26. Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M. MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway. Oncogene 2003; 22: 3463-3471
27. Somsel Rodman J, Wandinger-Ness A. Rab GTPases coordinate endocytosis. J Cell Sci 2000; 113(Pt 2): 183-192
28. Kamei T, Matozaki T, Takai Y. Mechanisms of cell adhesion and migration. Gan To Kagaku Ryoho 1999; 26: 1359-1366
29. Goldenring JR, Ray GS, Lee JR. Rab11 in displasia of Barrett's epithelia. Yale J Biol Med 1999; 72: 113-120
30. Burczynski ME, Lin HK, Penning TM. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res 1999; 59: 607-614
31. Palackal NT, Lee SH, Harvey RG, Blair IA, Penning TM. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J Biol Chem 2002; 277: 24799-24808
32. Hsu NY, Ho HC, Chow KC, Lin TY, Shih CS, Wang LS, Tsai CM. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 2001; 61: 2727-2731
33. Deng HB, Parekh HK, Chow KC, Simpkins H. Increased expression of dihydrodiol clehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J Biol Chem 2002; 277: 15035-15043
34. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 2000; 351(Pt 1): 67-77
35. Breyer-Pfaff U, Nill K. High-affinity stereoselective reduction of the enantiomers of ketotifen and ketonic nortriptyline metabolites by aldo-keto reductases from human liver. Biochem Pharmacol 1999; 59: 249-260
36. Shou M, Harvey RG, Penning TM. Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. Carcinogenesis 1993; 14: 475-482
37. Esterbauer H, Schaur RJ, Zollner H. forming propano-dGuo adducts which can lead to a pre-mutagenic lesion. Free Radic Biol Med 1991; 11: 81-128
38. Penning MT, Burczynski ME, Hung CF, McCoull KD, Palackal NT, Tsuruda LS. Dihydrodiol dehydrogenase and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem Res Toxicol 1999; 12: 1-18
39. Lee JS, Oh TY, Abn BO, Cho H, Kim WB, Kim YB, Surh YJ, Kim HJ, Hahm KB. Involvement of oxidative stress in experimentally induced reflex esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res 2001; 480-481: 189-200
40. Burczynski ME, Sridhar GR, Palackal NT, Penning TM. The reactive oxygen species- and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the α,β-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihyroxy-2-nonene. J Biol Chem 2001; 276: 2890-2897
41. Nadon L, Siemiatycki J, Dewar R, Krewski D, Gerin M. Cancer risk due to occupation exposure to polycyclic aromatic hydrocarbons. Am J Ind Med 1995; 28: 303-324
42. Lin HK, Jez JM, Overby AM, Burcynski ME, Peehl DM, Penning TM. Type 3 3-hydroxysteroid dehydrogenase (3-HSD) accumulate 5-DHTand activates the androgen receptor in human prostate cancer PC3 cell. Proc Am Assoc Cancer Res 2000; 41: 1510
43. Wang Q, Holmes DI, Powell SM, Lu QL, Waxman J. Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene. Cancer Lett 2002; 175: 63-69
44. Cehn FW, Ioannou YA. Ribosomal proteins in cell proliferation and apoptosis. Int Rev Immunol 1999; 18: 429-448
45. Spence J, Gali RR, Dittmar G, Sherman F, Karin M, Finley D. Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain. Cell 2000; 102: 67-76
46. Liu SC, Bassi DE, Zhang SY, Holoran D, Conti CJ, Klein-Szanto AJ. Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells. Mol Carcinog 2002; 34: 131-139